Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations

References

• AYNACIOGLU, A. S., CASCORBI, I., MRozixiEwicz, P.M. and ROPP, J. D., 1998, High frequency of CYP1A1 mutations in a Turkish population. Archives of Toxicology, 72, 215–218.
   PubMed Web of Science ®Google Scholar
• BAILEY, L. R., ROODI, N., DUPONT, W. D. AND PARL, F. F., 1998, Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Research, 58, 5038–5041.
   PubMed Web of Science ®Google Scholar
• BEJJANI, B. A., LEWIS, R. A., TOMEY, K. F., ANDERSON, K. L., DUEKER, D. K., JABAK, M., ASTLE W. F., OTTERUD, B., LEPPERT, M. and LUPSKI, J. R., 1998, Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. American Journal of Human Genetics, 62, 325–333.
   Google Scholar
• CASCORBI, I., BROCKMOLLER, J. and ROOTS, I., 1996, A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Research, 56, 4965–4969.
   PubMed Web of Science ®Google Scholar
• COSMA, G., CROFTS, F., TAIOLI, E., TONIOLO, P. and GARTE, S., 1993, Relationship between genotype and function of the human CY PlAl gene. journal of Toxicology and Environmental Health, 40, 309–316.
   PubMed Web of Science ®Google Scholar
• CROFTS, F., COSMA, G. N., CURRIE, D., TAIOLI, E., TONIOLO, P. and GARTE, S. J., 1993, A novel CY P1 A 1 gene polymorphism in African-Americans. Carcinogenesis, 14, 1729–1731.
   PubMed Web of Science ®Google Scholar
• D'ERRICO, A., TAIOLI, E., CHEN, X. and \Timis, P., 1996, Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers, 1, 149–173.
   Google Scholar
• DRAKOULIS, N., CASCORBI, I., BROCKMOLLER, J., GROSS, C. R. and ROOTS, I., 1994, Polymorphisms in the human CY P1 A 1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889A to G), and a T to C mutation in the 3'-flanking region. Clinical Investigations, 72, 240–248.
   PubMedGoogle Scholar
• ELTOM, S. E., LARSEN, M. C. and JEFCOATE, C. R., 1998, Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor. Carcinogenesis, 19, 1437–1444.
   PubMed Web of Science ®Google Scholar
• ESTELLER, M., GARCI A., MARTINEZ -PALONES, J. M., XERCAVINTS, J. and REVENTOS, J., 1997, Germ line polymorphisms in cytochrome P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis, 18, 2307–2311.
   Google Scholar
• GONZALEZ, F. J. and GELBOIN, H. V., 1994, Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metabolism Reviews, 26, 165–183.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P., HOSEA, N. A., PARIKH, A., BELL -PARIKH, L. C., JOHNSON, W. W., GILLAM E. M. J. and SHEMADA, T., 1998, Twenty years of biochemistry of human P450 s. Drug Metabolism and Disposition, 26, 1175–1178.
   Google Scholar
• GUENGERICH, F. P. and SHIMADA, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391–407.
   PubMed Web of Science ®Google Scholar
• HAYASHI, S., WATANABE, J. and KAWARIU, K., 1992, High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes. Japanese Journal of Cancer Research, 83, 866–870.
   PubMedGoogle Scholar
• HAYASHE, S. I., WATANABE, J., NAKACHI, K. and KAWARRI, K., 1991, Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. Journal of Biochemistry, 110, 407–411.
   PubMed Web of Science ®Google Scholar
• HIRVONEN, A., HUSGAFVEL -PUSIAINEN, K., KARJALAINEN, A., ANTTILA, S. and VAINIO, H., 1992, Point-mutational Mspl and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiology, Biomarkers and Prevention, 1, 485–489.
   Google Scholar
• HUANG, Z., FASCO, M. J., FIGGE, H. L., KEYOMARS, F. K. and KAMINSKY, L. S., 1996, Expression of cytochromes P450 in human breast tissue and tumors. Drug Metabolism and Disposition, 24, 899–905.
   PubMed Web of Science ®Google Scholar
• INouE, K., YAMAZAKI, H., ImPiA, K., AKASAKA, S., GUENGERICH, F. P. and SHEVIADA, T., 1997, Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations. Pharmacogenetics, 7, 103–113.
   PubMedGoogle Scholar
• KAWAJIRI, K., NAKACHI, K., Imm, K., Yosoll, A., SollsoDA, N. and WATANABE, J., 1990, Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Letters, 263, 131–133.
   PubMed Web of Science ®Google Scholar
• KAWAJIRI, K., WATANABE, J. and HAYASHI, S., 1996, Identification of allelic variants of the human CYP1A1 gene. Methods in Enzymology, 272, 226–232.
   PubMed Web of Science ®Google Scholar
• KELSEY, K. T., WIENCKE, J. K. and SPrtz, M. R., 1994, A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis, 15, 1121–1124.
   PubMed Web of Science ®Google Scholar
• KUMEDA, Y. and ASAO, T., 1996, Single-strand conformation polymorphism analysis of PCR-amplified ribosomal DNA internal transcribed spacers to differentiate species of Aspergillus section Flavi. Applied and Environmental Microbiology, 62, 2947–2952.
   PubMed Web of Science ®Google Scholar
• LARSEN, M. C., ANGUS, W. G. R., BRAKE, P. B., ELTOM, S. E., Suxow, K. A. and JEFCOATE, C. R., 1998, Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Research, 58, 2366–2374.
   Google Scholar
• LIEHR, J. G. and Roca, M. J., 1996, 4—Hydroxylation of estrogens as marker of human mammary tumors. Proceedings of the National Academy of Sciences, USA, 93, 3294–3296.
   PubMed Web of Science ®Google Scholar
• NAKACHE, K., Imm, K., HAYASHI, S. and KAWAJIRI, K., 1991, Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research, 51, 5177–5180.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., OKUDA, K. and NEBERT, D. W., 1993, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology, 12, 1–51.
   PubMed Web of Science ®Google Scholar
• NELSON, D. R., KOYMANS, L., KAMATAKI, T., STEGEMAN J. J., FEYEREISEN, R., WAXMAN, D. J., WATERMAN, M. R., GOTOH, O., COON, M. J., ESTABROOK, R. W., GUNSALUS, I. C. and NEBERT D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1–42.
   Google Scholar
• SHIMADA, T., HAYES, C. L., YAMAZAKI, H., AMIN, S., HECHT, S. S., GUENGERICH, F. P. and SUTTER, T. R., 1996, Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Research, 56, 2979–2984.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., WATANABE, J., KAWAJIRI, K., SUTTER, T. R., GUENGERICH, F. P., GILLAM, E. M. J. and INouE, K., 1999, Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis, 20, 1607–1613.
   Google Scholar
• SHIMADA, T., WUNSCH, R. M., HANNA, I. H., SUTTER, T. R., GUENGERICH, F. P. and GILLAM, E. M. J., 1998, Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Archives of Biochemistry and Biophysics, 357, 111–120.
   PubMed Web of Science ®Google Scholar
• SHIMADA, T., YAMAZAKI, H., MimuRA, M., INui, Y. and GUENGERICH, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414–423.
   PubMed Web of Science ®Google Scholar
• SPINK, D. C., EUGSTER, H. P., LINCOLN II, D. W., SCHUETZ, J. D., SCHUETZ, E. G., JOHNSON, J. A., KAMINSKY, L. S. and GIERTHY, J. F., 1992, 17/3-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8—tetrachlorodibenzo -p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Archives of Biochemistry and Biophysics, 293, 342–348.
   PubMed Web of Science ®Google Scholar
• SPINK, D. C., SPiNx, B. C., CAO, J. Q., GIERTHY, J. F., HAYES, C. L., Li, Y. and SUTTER, T. R., 1997, Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. Journal of Steroid and Biochemical Molecular Biology, 62, 223–232.
   PubMed Web of Science ®Google Scholar
• SUTTER, T. R., TANG, Y. M., HAYES, C. L., Wo, Y.-Y. P., JABS, W., Li, X., YIN, H., CODY, C. W. and GREENLEE, W. F., 1994, Complete c DNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. Journal of Biological Chemistry, 269, 13092–13099.
   Google Scholar
• TAIOLI, E., CROFTS, F., TRACHMAN, J., BAYO, S., TONIOLO, P. and GARTE, S. J., 1995, Racial differences in CYP1A1 genotype and function. Toxicology Letters, 77, 357–362.
   PubMed Web of Science ®Google Scholar
• WATANABE, J., SHEMADA, T., GILLAM, E. M. J., IKUTA, T., SUEMATSU, K., HIGASHI, Y., GOTOH, O. and KAWAJIRI, K., 1999, Association of CYPIB1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics (in press).
   Google Scholar
• YAMAZAKI, H., INouE, K., TURVY, C. G., GUENGERICH, F. P. and SHIMADA, T., 1997, Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome P450 enzymes. Drug Metabolism and Disposition, 25, 168–174.
   PubMed Web of Science ®Google Scholar